Sorrento Therapeutics Inc (SRNE)

[1776club]

Everybody is dumping shares of Sorrento...
Several institutional investors have recently made changes to their positions in SRNE. BlackRock Inc. lifted its position in shares of Sorrento Therapeutics by 17.3% in the fourth quarter. BlackRock Inc. now owns 17,619,678 shares of the biopharmaceutical company's stock worth $120,253,000 after purchasing an additional 2,603,120 shares in the last quarter. Northern Trust Corp lifted its stake in shares of Sorrento Therapeutics by 9.1% in the fourth quarter. Northern Trust Corp now owns 2,895,917 shares of the biopharmaceutical company's stock valued at $19,765,000 after buying an additional 240,852 shares during the period. Morgan Stanley lifted its position in shares of Sorrento Therapeutics by 206.8% in the 3rd quarter. Morgan Stanley now owns 2,742,494 shares of the biopharmaceutical company's stock worth $30,580,000 after acquiring an additional 1,848,618 shares during the period. Charles Schwab Investment Management Inc. boosted its stake in Sorrento Therapeutics by 11.1% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,522,549 shares of the biopharmaceutical company's stock worth $10,392,000 after buying an additional 152,480 shares in the last quarter. Finally, Nuveen Asset Management LLC boosted its position in shares of Sorrento Therapeutics by 5.0% during the 4th quarter. Nuveen Asset Management LLC now owns 1,276,134 shares of the biopharmaceutical company's stock valued at $8,710,000 after acquiring an additional 60,315 shares in the last quarter. 27.43% of the stock is currently owned by institutional investors.
...into their portfolios.